Biotech

Find Biotech companies London ads at NewsNow Classifieds/Jobs

Health Care Sector Update for 11/12/2018: OPK,LCI,EIDX,ABMD Nasdaq21:09 12-Nov-18
      
Record Biotech IPO May Be Worth the $7 Billion The Wall Street Journal17:21 12-Nov-18
      
Amarin: Addressing The Mineral Oil Issue Seeking Alpha23:06 12-Nov-18
      
Amarin, Vascepa, and mineral oil. There is more to consider with this fish-oil drug story STAT18:50 12-Nov-18
      
Scientists use patients' own cells and materials to engineer fully personalized tissue implants … Phys.org17:39 12-Nov-18
      
Amarin's Vascepa trial stirs data debate as stock drops 10% BioPharma Dive17:03 12-Nov-18
      
Patients' own cells and materials used to create personalized tissue implants of any kind EurekAlert!16:38 12-Nov-18
      
Medicon Valley: How Denmark and Sweden are ‘bridging’ the biotech gap Biopharma Reporter16:37 12-Nov-18
      
Coherus plots 33% biosim discount to battle Amgen’s Neulasta FiercePharma16:03 12-Nov-18
      
MaxCyte buddies-up with Gilead subsidiary Web Financial Group14:22 12-Nov-18
      
Short Sellers Raise the Stakes in Major Biotechs 24/7 Wall St.13:54 12-Nov-18
      
Why Celgene's Stock Nosedived in October The Motley Fool13:33 12-Nov-18

In the last half-hour

First fully personalized tissue implant engineered from patient's own materials and cells News-Medical.Net05:15

In the last 2 hours

INFI Hits All-time Low, MESO Gets Blasted Over MPC-150-IM Data, EYEN On Watch RTT News03:47

In the last 6 hours

With $98M investment, Nestlé bumps up its Aimmune stake to 19% FierceBiotech23:43 12-Nov-18

In the last 8 hours

As Amarin stock drops, CEO says investors should 'understand our data better' CNBC23:16 12-Nov-18

CORRECTION: Unum Therapeutics to Host Investor Event on its Efforts to Realize the Promise of T Cell Therapies in Solid … GlobeNewswire23:14 12-Nov-18

Amarin: Addressing The Mineral Oil Issue Seeking Alpha23:06 12-Nov-18

DiaMedica Therapeutics Has Applied to List its Common Shares on Nasdaq, Announces Share Consolidation GlobeNewswire21:52 12-Nov-18

Kane Biotech Announces Extension of Warrants GlobeNewswire21:40 12-Nov-18

Yesterday

Health Care Sector Update for 11/12/2018: OPK,LCI,EIDX,ABMD Nasdaq21:09 12-Nov-18

Why Dynavax Technologies Corporation Fell 20.2% in October The Motley Fool20:45 12-Nov-18

Catalysts Approaching for U.S. Developer of Cancer Therapeutics Investorideas.com20:34 12-Nov-18

Biotech Announces Preclinical Data on its Intravaginal Rings at Meeting Investorideas.com20:14 12-Nov-18

Five things we learned from Moderna’s pre-IPO information dump STAT19:50 12-Nov-18

Health Care Sector Update for 11/12/2018: LCI,EIDX,ABMD Nasdaq19:35 12-Nov-18

BioMarin and Believe Limited Announce the Debut of 'Hemophilia: The Musical' PR Newswire (Press Release)19:33 12-Nov-18

Single-Use Bioprocessing Equipment Trends and Adoption by CMOs PharmTech.com19:20 12-Nov-18

Amarin, Vascepa, and mineral oil. There is more to consider with this fish-oil drug story STAT18:50 12-Nov-18

'Bhashani's belief in secular struggle was unequivocal' The Daily Star, Bangladesh18:25 12-Nov-18

GSK pancreatic cancer drug heads to phase 1 combo with Merck's Keytruda after positive mouse… FierceBiotech17:44 12-Nov-18

Scientists use patients' own cells and materials to engineer fully personalized tissue implants … Phys.org17:39 12-Nov-18

Shifa Biomedical Corporation Presents Preclinical Data on P-21, a Novel Orally Active PSCK9 Antagonist, at the American … GlobeNewswire17:34 12-Nov-18

Agricultural biotech advocates to share stories in D.C. Cornell Chronicle17:30 12-Nov-18

Record Biotech IPO May Be Worth the $7 Billion The Wall Street Journal17:21 12-Nov-18

Aurobindo Pharma to acquire under development product, related assets from Advent for $12.5mn The Times of India17:13 12-Nov-18

Amarin's Vascepa trial stirs data debate as stock drops 10% BioPharma Dive17:03 12-Nov-18

Gilead names Michael Boyd VP of government affairs, policy PRWeek17:02 12-Nov-18

BB Healthcare expects to raise £131m in share issue HealthInvestor Magazine16:48 12-Nov-18

Patients' own cells and materials used to create personalized tissue implants of any kind EurekAlert!16:38 12-Nov-18

Medicon Valley: How Denmark and Sweden are ‘bridging’ the biotech gap Biopharma Reporter16:37 12-Nov-18

Merck KGaA launches campaign to bring MS insights to life FiercePharma16:33 12-Nov-18

BioMarin debuts teen-created hemophilia musical FiercePharma16:33 12-Nov-18

Coherus plots 33% biosim discount to battle Amgen’s Neulasta FiercePharma16:03 12-Nov-18

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants GlobeNewswire15:53 12-Nov-18

Why Amarin Corporation's Stock Is Falling Today The Motley Fool15:43 12-Nov-18

Nestlé ups its bet on Aimmune’s peanut allergy drug to $276M as NDA filing looms, rivalry intensifies ENDPOINTS14:44 12-Nov-18

Big Pharma's China Q3, Genentech suit and more—FiercePharmaAsia FiercePharma14:42 12-Nov-18

Why Intercept Pharmaceuticals, Inc. Stock Broke Down in October The Motley Fool14:33 12-Nov-18

REDUCE-IT reveals high dose of pure EPA in omega-3 drug cuts risk of cardiovascular events EurekAlert!14:28 12-Nov-18

MaxCyte buddies-up with Gilead subsidiary Web Financial Group14:22 12-Nov-18

INVESTOR REMINDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and… GlobeNewswire14:13 12-Nov-18

Why Madrigal Pharmaceuticals Stock Slumped in October The Motley Fool14:03 12-Nov-18

Short Sellers Raise the Stakes in Major Biotechs 24/7 Wall St.13:54 12-Nov-18

Why Celgene's Stock Nosedived in October The Motley Fool13:33 12-Nov-18

VistaGen Therapeutics Receives Notices of Allowance in Australia and Japan for AV-101 Patents Covering Treatment of… GlobeNewswire13:32 12-Nov-18

Sanyal Biotechnology and Innovate Biopharmaceuticals Present Data at AASLD Validating a Proprietary “Leaky Gut” Assay… GlobeNewswire13:12 12-Nov-18

Organovo Partners With IIAM on Multi-Year Clinical Biomaterial Sourcing Agreement GlobeNewswire13:12 12-Nov-18

Why AbbVie's Stock Cratered in October The Motley Fool13:02 12-Nov-18

Aptinyx Exploratory Clinical Studies Provide First Evidence that NYX-2925 Elicits Rapid, Persistent, NMDAr-Mediated… GlobeNewswire12:12 12-Nov-18

Assembly Biosciences Presents Final Results of Phase 1b Study of ABI-H0731 at 2018 AASLD GlobeNewswire12:12 12-Nov-18

Oncolytics Biotech® Reports 2018 Third Quarter Financial Results and Provides Corporate Update GlobeNewswire12:02 12-Nov-18

ContraFect Appoints Michael Messinger as Chief Financial Officer GlobeNewswire12:02 12-Nov-18

Mersana Scientists Present Updates on XMT-1522, XMT-1536 and the Dolaflexin Platform at World ADC 2018 GlobeNewswire12:02 12-Nov-18

Oxford BioDynamics forms new alliance to identify autism biomarkers Verdict Medical Devices11:06 12-Nov-18

Moderna files record $500m IPO for RNA pipeline PMLiVE10:17 12-Nov-18

MOLOGEN AG: Lefitolimod - First clinical data in combination with a checkpoint inhibitor and… DGAP09:55 12-Nov-18

AC Immune to Present at the Jefferies 2018 London Healthcare Conference GlobeNewswire09:10 12-Nov-18

Biotech Bootcamp sparks interest in science International Baccalaureate (Weblog)09:09 12-Nov-18

The First Pellino-1 Inhibitor BBT-401 Confirms Its Safety and Tolerability from the Phase I… PR Newswire (Press Release)08:06 12-Nov-18

Scancell Holdings Plc Scancell to Present at Two Conferences ADVFN07:51 12-Nov-18

Antibiotic resistance spreading across Europe European Biotechnology News07:37 12-Nov-18

Lupin gets EIR from USFDA for its Nagpur facility The Times of India06:47 12-Nov-18

USFDA completes Biocon’s Bengaluru plant inspection The Hindu Business Line06:46 12-Nov-18

Zydus Cadila gets USFDA nod for anti-fungal ointment The Times of India06:27 12-Nov-18

Addex to Present at the Biotech and Money Inv€$tival Showcase and Participate in the Jefferies London Healthcare… GlobeNewswire06:09 12-Nov-18

Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients The Times of India06:07 12-Nov-18

CRISIL ratings for Indian debt instruments-Nov 12 Reuters05:39 12-Nov-18

USFDA completes inspection of Biocon#39;s Bengaluru plant with no observations MoneyControl.com05:35 12-Nov-18

Biocon clears USFDA audit of Bengaluru plant with zero observations MoneyControl.com04:04 12-Nov-18

How Bristol-Myers Squibb Company Fell $18.8 Billion in October The Motley Fool01:18 12-Nov-18

Global Microplate Absorbance Reader Market Projected to Augment at a Notable CAGR during the Forecas USPRwire00:48 12-Nov-18

In the last 7 days

Fate Therapeutics Announces Encouraging Dose-Escalation Clinical Data of FATE-NK100 and Provides Regulatory Update on… GlobeNewswire22:47 11-Nov-18

Amazon Joins Eli Lilly And Abiomed As Strong Buys Forbes18:40 11-Nov-18

Blueprint Medicines: An Infrequent, Timely Buy Seeking Alpha17:00 11-Nov-18

Irish firm Amarin confirms heart drug success The Irish Times15:58 11-Nov-18

My internship Blending biotech and writing The Hindu14:39 11-Nov-18

ODYSSEY OUTCOMES Investigators Highlight at AHA that Praluent® (alirocumab) Injection Was… PR Newswire (Press Release)13:22 11-Nov-18

Better Buy: Amgen Inc. vs. Pfizer Inc. The Motley Fool11:41 11-Nov-18

Detailed results show Amarin fish oil offered a major cardiovascular benefit — but come with a… STAT20:03 10-Nov-18

Here's Why Sangamo Therapeutics Inc. Fell 25.3% in October The Motley Fool12:24 10-Nov-18

#SITC18: Another underwhelming performance for STING damages Aduro’s already suffering share price ENDPOINTS11:47 10-Nov-18

Validea Peter Lynch Strategy Daily Upgrade Report - 11/10/2018 Nasdaq10:04 10-Nov-18

Moderna shoots for $500M IPO, the biggest in biotech history FierceBiotech01:05 10-Nov-18

Hagens Berman Reminds AbbVie (NYSE: ABBV) Investors of Ongoing Investigation of AbbVie's Humira … PR Newswire (Press Release)23:32 9-Nov-18

Progenics: Inflection Point In 2019 Seeking Alpha23:06 9-Nov-18

Flexion Therapeutics: Reversal In Sentiment? Seeking Alpha23:06 9-Nov-18

This Biotech Stock Just Boomeranged On Cancer Treatment Studies Investors Business Daily22:52 9-Nov-18

The president of the company headed for the biggest IPO in biotech history has a surprisingly… Business Insider22:42 9-Nov-18

Waiting for bluebird bio to Sing at ASH The Motley Fool21:41 9-Nov-18

Abeona Therapeutics Reports Third Quarter 2018 Financial Results and Business Highlights GlobeNewswire21:26 9-Nov-18

Health Care Sector Update for 11/09/2018: JAZZ,ACRX,ACET,NTRA Nasdaq21:22 9-Nov-18

Biotech giant Moderna files for IPO CNBC21:22 9-Nov-18

A biotech unicorn valued at more than $7 billion just took a big step towards going public Business Insider UK21:15 9-Nov-18

Pharmaceutical Industry Report Sheds Light on Gray Areas of Scientific Publications Process PR Newswire (Press Release)20:57 9-Nov-18

Biotech company Moderna files for an IPO MarketWatch20:55 9-Nov-18

Big dreams, big pay and a big IPO: Moderna lights up a pitch for a record $500M biotech IPO ENDPOINTS20:51 9-Nov-18

Moderna files for what could be largest biotech IPO ever Axios20:21 9-Nov-18

Moderna aims to raise $500 million in biotech’s largest-ever public offering STAT19:59 9-Nov-18

Unum Therapeutics to Present Preclinical Data on Applications of ACTR Proprietary Technology Platform in Solid Tumors… GlobeNewswire19:34 9-Nov-18

Health Care Sector Update for 11/09/2018: ACET,ACRX,NTRA Nasdaq19:15 9-Nov-18

Shire celebrates 'critical milestones' in Dunboyne construction work The Meath Chronicle19:04 9-Nov-18

Symic Bio Selected for "The Best of The Liver Meeting 2018" at AASLD PR Newswire (Press Release)18:50 9-Nov-18

Biotech leaders call for free press Nature Research Ecology & Evolution Community16:44 9-Nov-18

SITC18: Aduro finds some activity with STING agonist FierceBiotech16:31 9-Nov-18

more
13 Nov 05:15

Biotech

Top Stories

In the News Now

Biotech

NewsNow Classifieds » Jobs » Top Searches

Top Stories

In the News Now